Lupeng Pharmaceutical's Fourth-Generation BTK Inhibitor Rocbrutinib Approved in China for Relapsed or Refractory Mantle Cell Lymphoma
GUANGZHOU, China, June 4, 2026 /PRNewswire/ -- Lupeng Pharmaceutical today announced that the National Medical Products Administration (NMPA) has granted accelerated approval to rocbrutinib (development code: LP-168) for the treatment of adult...
ROCK & ROLL HALL OF FAME ANNOUNCES ADDITIONAL PRESENTERS AND PERFORMERS FOR 2025 INDUCTION CEREMONY
More Stars Join the Celebration of Music's Highest Honor, Streaming Live on Disney+ Saturday, Nov. 8 NEW YORK, Oct. 29, 2025 /PRNewswire/ -- The Rock & Roll Hall of Fame Foundation unveils additional music icons and cultural trailblazers joining...